Neuropace Inc. (NPCE) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Neuropace Inc., updated every trading day.
Health Care · Medical/Dental Instruments
Price
$12.93
−0.69% today
Market cap
$447M
Overall quality
—
Kronos AI 30-day
+9.6%
8 of 8 simulated paths end higher
Neuropace Inc. (NPCE) is a Health Care company in Medical/Dental Instruments, worth $447M. It trades at $12.93, down 0.69% today. 5 analysts' average target of $19.67 implies +52.1% from today's price. Kronos AI's 30-day forecast is +9.6% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $19.67 |
| Low – high | $18.00 – $21.00 |
| Analysts | 5 |
| Upside to average | +52.1% |
Kronos AI 30-day forecast
| Expected close | $14.27 (+9.6%) |
| Likely range | +6.8% … +15.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Medical/Dental Instruments
For information only, not investment advice. Prices updated: 2026-10-29.